Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

被引：312
|
作者：
Abbasi, F [1 ]
Asagmi, T [1 ]
Cooke, JP [1 ]
Lamendola, C [1 ]
McLaughlin, T [1 ]
Reaven, GM [1 ]
Stuehlinger, M [1 ]
Tsao, PS [1 ]
机构：
[1] Stanford Univ, Med Ctr, Sch Med, Falk CVRC,Div Cardiovasc Med, Stanford, CA 94305 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2001年 / 88卷 / 10期
关键词：
D O I：
10.1016/S0002-9149(01)02063-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Increased risk of coronary heart disease in patients with type 2 diabetes cannot be accounted for by differences in conventional risk factors. This study demonstrates that plasma concentrations of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, are increased in patients with type 2 diabetes, thereby identifying a new and potentially important coronary heart disease risk factor in this patient population.
引用
收藏
页码：1201 / +
页数：4
相关论文
共 50 条
  • [31] Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow
    Selcuk, Mehmet Timur
    Selcuk, Hatice
    Temizhan, Ahmet
    Maden, Orhan
    Ulupinar, Hakan
    Baysal, Erkan
    Ozeke, Oman
    Sasmaz, Ali
    CORONARY ARTERY DISEASE, 2007, 18 (07) : 545 - 551
  • [32] ADMA (asymmetric dimethylarginine) and angiogenic potential in patients with type 2 diabetes and prediabetes
    Wieczor, Radoslaw
    Wieczor, Anna M.
    Kulwas, Arleta
    Rosc, Danuta
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (02) : 153 - 162
  • [33] Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression
    Selley, ML
    JOURNAL OF AFFECTIVE DISORDERS, 2004, 80 (2-3) : 249 - 256
  • [34] Plasma levels of asymmetric dimethylarginine (ADMA) in children with type 1 diabetes mellitus: a hyperinsulinemic euglycemic clamp study
    Marcovecchio, M. Loredana
    Dalton, R. Neil
    Turner, Charles
    Saukkonen, Tero
    Widmer, Barry
    Dunger, David B.
    HORMONE RESEARCH, 2006, 65 : 52 - 52
  • [35] Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes
    Marcovecchio, M. Loredana
    Widmer, Barry
    Dunger, David B.
    Dalton, R. Neil
    CLINICAL SCIENCE, 2008, 115 (11-12) : 361 - 369
  • [36] Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus
    Mittermayer, F
    Pleiner, J
    Krzyzanowska, K
    Wiesinger, GF
    Francesconi, M
    Wolzt, M
    WIENER KLINISCHE WOCHENSCHRIFT, 2005, 117 (23-24) : 816 - 820
  • [37] Increased plasma asymmetric dimethylarginine is associated with cognitive deficits in patients with schizophrenia
    Yang, Yuan-Jian
    Xiong, Jian-Wen
    Zhao, Ying
    Zhan, Jin-Qiong
    Chen, Hai-Bo
    Yan, Kun
    Hu, Mao-Rong
    Yu, Bin
    Wei, Bo
    PSYCHIATRY RESEARCH, 2016, 246 : 480 - 484
  • [38] Erythropoietin treatment in hemodialyzed patients is associated with increased asymmetric dimethylarginine concentrations.
    Mishra, S
    Tevlin, MT
    Wang, YB
    Acchiardo, SR
    Kang, ES
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 57A - 57A
  • [39] Serum asymmetric dimethylarginine and arginine levels predict microvascular and macrovascular complications in type 2 diabetes mellitus
    Ganz, Tali
    Wainstein, Julio
    Gilad, Suzan
    Limor, Rona
    Boaz, Mona
    Stern, Naftali
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2017, 33 (02)
  • [40] Association of type 2 diabetes mellitus with plasma organochlorine compound concentrations
    Eden, Paul R.
    Meek, Edward C.
    Wills, Robert W.
    Olsen, Eric V.
    Crow, J. Allen
    Chambers, Janice E.
    JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY, 2016, 26 (02) : 207 - 213
12345